Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasm
arising in the stomach. These tumors were previously classified as smooth muscle tumors …

Background Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the
digestive tract, among which patients with distant metastases tend to have a poor prognosis …

Accurate risk stratification of gastrointestinal stromal tumors (GISTs) has become
increasingly important owing to emerging adjuvant systemic treatments. All GISTs have …

Purpose To explore the prognostic value of mutations in c-KIT and PDGFR-α genes with
respect to relapse-free survival (RFS) in patients with gastrointestinal stromal tumors (GIST) …

Background The introduction of adjuvant imatinib in gastrointestinal stromal tumors (GISTs)
raised debate over the accuracy of National Institutes of Health risk criteria and the …

Background The aim of the study was to analyze the surgical possibilities of unresectable
and/or metastatic GIST CD117 (+) patients during imatinib treatment. Methods We analyzed …

Background Tyrosine kinase inhibitors have been shown to have marked clinical efficacy in
patients with unresectable or metastatic gastrointestinal stromal tumors (GIST). We …

Background Gastrointestinal stromal tumors (GIST) are mesenchymal tumors of the
gastrointestinal tract, usually kit-positive, that are believed to originate from interstitial cell of …

AIM: To analyze GIST outcome after primary resection and to determine if a new grading
system could adequately predict there prognosis. METHODS: A retrospective review (1993 …

Hypothesis A gastrointestinal stromal tumor (GIST) staging system can be created with the
Surveillance, Epidemiology and End Results (SEER) database. Design A review of records …